Quia Pharma AB (publ)

    Quia Pharma AB (publ)

    SSTO:QUIA
    - -
    SEK
    - -
    - -
    Quia Pharma AB (publ)
    STO:QUIA
    (Nasdaq Stockholm)

    Recent

    price

    - -

    P/E

    ratio

    - -

    div

    yld

    - -

    ROIC.AI

    2009
    2010
    2011
    2012
    2013
    2014
    2015
    2016
    2017
    2018
    2019
    2020
    2021
    2022
    2023
    2024
    TTM
    SEK
    157.43
    149
    192.31
    144.52
    200.97
    142.65
    17.82
    12.18
    - -
    - -
    - -
    1.67
    - -
    - -
    - -
    - -
    - -
    Revenue per Share
    0.74
    -16.69
    5.79
    -47.48
    -25.38
    -10.37
    3.97
    127.62
    -6.93
    -15.33
    -20.02
    -24.86
    -11.83
    -0.09
    -0.03
    -0.03
    -4.73
    Basic EPS, GAAP
    24.32
    30.31
    30.45
    -80.18
    33.95
    22.73
    -21.64
    23.91
    - -
    -17.72
    -20.48
    -27.64
    -16.98
    -0.1
    -0.05
    -0.01
    -5.6
    Free Cash Flow per Basic Share
    - -
    - -
    - -
    16.3
    16.3
    8.16
    - -
    17.82
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Dividend per Share
    39.87
    22.44
    44.91
    -8.36
    13.39
    39.13
    66.4
    206.6
    -14.11
    -20.03
    -29.8
    -32.85
    -27.27
    -0.17
    -0.03
    -0.01
    -9.26
    Book Value per Share
    199.86
    190.28
    215.89
    149.78
    111.85
    99.15
    124.37
    245.27
    -0.56
    -6.47
    -18.28
    -9.03
    -9.86
    -0.07
    -0.04
    - -
    -3.95
    Tangible Book Value per Share
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    1
    1
    1
    1
    2
    236
    657
    1,265
    4
    Basic Weighted Avg Shares
    10
    10
    12
    9
    13
    9
    1
    1
    - -
    - -
    - -
    2
    - -
    - -
    - -
    - -
    - -
    Sales/Revenue/Turnover
    11.45
    0.21
    4.75
    -29.58
    -10.84
    -10.89
    18.31
    -104.91
    - -
    - -
    - -
    -1,339.76
    - -
    - -
    - -
    - -
    - -
    Operating Margin (%)
    1
    2
    2
    1
    1
    1
    1
    - -
    - -
    - -
    1
    1
    2
    3
    4
    23
    3
    Depreciation Expense
    - -
    -1
    - -
    -3
    -2
    -1
    - -
    10
    -4
    -12
    -20
    -28
    -20
    -20
    -17
    -33
    -20
    Net Income, GAAP
    93.28
    - -
    52.04
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Effective Tax Rate (%)
    0.47
    -11.2
    3.01
    -32.86
    -12.63
    -7.27
    22.28
    1,047.49
    - -
    - -
    - -
    -1,488.98
    - -
    - -
    - -
    - -
    - -
    Profit Margin (%)
    5
    6
    8
    6
    4
    4
    1
    16
    2
    -3
    -5
    -10
    - -
    -2
    -25
    -5
    -2
    Working Capital
    1
    1
    1
    1
    1
    1
    - -
    - -
    3
    2
    14
    1
    17
    15
    - -
    - -
    15
    LT Debt
    18
    14
    14
    10
    7
    6
    8
    18
    2
    1
    -9
    - -
    - -
    2
    15
    12
    2
    Total Equity
    0.4
    - -
    1.89
    - -
    - -
    - -
    2.76
    -7.19
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Return on Invested Capital (%)
    1.68
    - -
    12.65
    - -
    - -
    - -
    11.44
    95.64
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Return on Capital (%)
    1.52
    -53.56
    17.18
    - -
    - -
    -39.51
    7.53
    96.69
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Return on Common Equity (%)

    Capital Structure

    SEK

    •

    in mil. unless spec.
    Jun'22
    Sep'22
    Dec'22
    ST Debt
    - -
    - -
    - -
    LT Borrowings
    15
    15
    15
    LT Finance Leases
    - -
    - -
    - -
    Preferred Equity and Hybrid Capital
    - -
    - -
    - -
    Shares Outstanding
    6
    6
    6
    Market Capitalization
    28
    32
    55

    Working Capital

    SEK

    •

    in mil. unless spec.
    Jun'22
    Sep'22
    Dec'22
    Total Current Assets
    13
    8
    4
    Cash, Cash Equivalents & STI
    12
    7
    3
    Accounts Receivable, Net
    - -
    - -
    - -
    Inventories
    - -
    - -
    - -
    Total Current Liabilities
    4
    5
    6
    Payables & Accruals
    - -
    - -
    - -
    ST Debt
    - -
    - -
    - -
    Deferred Revenue
    - -
    - -
    - -

    Growth Rates

    SEK

    •

    in mil. unless spec.

    (avg. rate of change)

    10 years
    5 years
    1 year
    Total Equity
    904.65%
    2,145.77%
    -21.95%
    Free Cash Flow
    - -
    1.25%
    -69.31%
    Net Income, GAAP
    366.48%
    19.68%
    102.02%
    Sales/Revenue/Turnover
    - -
    - -
    - -
    Total Cash Common Dividend
    - -
    - -
    - -

    Quarterly Revenue

    SEK

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2023
    - -
    - -
    - -
    - -
    - -
    2024
    - -
    - -
    - -
    - -
    - -
    2025
    - -
    - -
    - -
    - -
    - -

    Quarterly Earnings Per Share

    SEK

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2023
    - -
    - -
    - -
    - -
    -0.03
    2024
    - -
    - -
    - -
    - -
    -0.03
    2025
    - -
    - -
    - -
    - -
    - -

    Quarterly Dividends Per Share

    SEK

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2023
    - -
    - -
    - -
    - -
    - -
    2024
    - -
    - -
    - -
    - -
    - -
    2025
    - -
    - -
    - -
    - -
    - -
    Similar Companies
    Business